Evidence map›Paper›PMID 22089318›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Camron D Bryant, Clarissa C Parker, Lili Zhou, Christopher Olker, Ramalakshmi Y Chandrasekaran, Travis T Wager, Valerie J Bolivar, Andrew S Loudon, Martha H Vitaterna, Fred W Turek and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Bmal1 Modulates Striatal cAMP Signaling and Motor Learning.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Neural plasticity · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Camron D BryantDepartment of Human Genetics, University of Chicago, Chicago, IL 60637, USA.
Clarissa C Parker
Lili Zhou
Christopher Olker
Ramalakshmi Y Chandrasekaran
Travis T Wager
Valerie J Bolivar
Andrew S Loudon
Martha H Vitaterna
Fred W Turek
Abraham A Palmer
Northwestern University · USUniversity of Chicago · USPfizer (United States) · USNew York State Department of Health · USUniversity of Manchester · GB

Funding

NEUROPSYCHOPHARMACOLOLGY TRG FOR DRUG ABUSE RESEARCHT32DA007255 · NIDA · UNIVERSITY OF CHICAGO · PI VEZINA, PAUL R · 1991 to 2012
$5.9M
Systems Genetic Analysis of Methamphetamine's Motivational Effects in a Mouse AILR01DA021336 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2006 to 2015
$4.0M
Genome-wide association studies in outbred miceR01GM097737 · NIGMS · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2011 to 2014
$1.9M
FINDING GENES THAT CAUSE QLT FOR FEAR LEARNING AND ANXIETYR01MH079103 · NIMH · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2007 to 2011
$1.9M
Genetics of complex behaviors in the mouse.R01MH068013 · NIMH · WADSWORTH CENTER · PI BOLIVAR, VALERIE J · 2003 to 2007
$1.7M
Genetic Basis of Opioid Reward and Aversion in MiceR00DA029635 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2013 to 2016
$750k
Weighted genome-wide association study of amphetamine sensitivity in humansR03DA027545 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2009 to 2010
$466k
Novel Methods to Map Stimulant QTLs in Advanced Intercross LinesR21DA024845 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2008 to 2009
$422k
Genetic Basis of Opioid Reward and Aversion in MiceK99DA029635 · NIDA · UNIVERSITY OF CHICAGO · PI BRYANT, CAMRON D · 2011 to 2012
$296k
Translational Genetics and Dopamine Signaling in Sensitivity to AmphetaminesF32DA026697 · NIDA · UNIVERSITY OF CHICAGO · PI BRYANT, CAMRON D · 2009 to 2009
$50k
NIDA NIH HHS F32 DA026697NIDA NIH HHS F32DA026697NIDA NIH HHS K99 DA029635NIDA NIH HHS K99DA029635NIDA NIH HHS R00 DA029635NIDA NIH HHS R01 DA021336NIDA NIH HHS R01DA021336NIDA NIH HHS R03 DA027545NIDA NIH HHS R21 DA024845NIDA NIH HHS T32 DA007255NIDA NIH HHS T32DA007255NIGMS NIH HHS R01 GM097737NIMH NIH HHS R01 MH068013NIMH NIH HHS R01MH068013NIMH NIH HHS R01 MH079103NIMH NIH HHS R01MH079103
6 · The paper itself

Abstract

Csnk1e, the gene encoding casein kinase 1-epsilon, has been implicated in sensitivity to amphetamines. Additionally, a polymorphism in CSNK1E was associated with heroin addiction, suggesting that this gene may also affect opioid sensitivity. In this study, we first conducted genome-wide quantitative trait locus (QTL) mapping of methamphetamine (MA)-induced locomotor activity in C57BL/6J (B6) × DBA/2J (D2)-F(2) mice and a more highly recombinant F(8) advanced intercross line. We identified a QTL on chromosome 15 that contained Csnk1e (63-86 Mb; Csnk1e=79.25 Mb). We replicated this result and further narrowed the locus using B6.D2(Csnk1e) and D2.B6(Csnk1e) reciprocal congenic lines (78-86.8 and 78.7-81.6 Mb, respectively). This locus also affected sensitivity to the μ-opioid receptor agonist fentanyl. Next, we directly tested the hypothesis that Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Mice harboring a null allele of Csnk1e showed an increase in locomotor activity following MA administration. Consistent with this result, coadministration of a selective pharmacological inhibitor of Csnk1e (PF-4800567) increased the locomotor stimulant response to both MA and fentanyl. These results show that a narrow genetic locus that contains Csnk1e is associated with differences in sensitivity to MA and fentanyl. Furthermore, gene knockout and selective pharmacological inhibition of Csnk1e define its role as a negative regulator of sensitivity to psychostimulants and opioids.

Indexed as

Analgesics, OpioidAnimalsCasein Kinase 1 epsilonCentral Nervous System StimulantsDrug ResistanceFemaleGenome-Wide Association StudyMaleMiceMice, Inbred C57BLMice, Inbred DBAMice, Inbred StrainsMice, KnockoutMotor ActivityQuantitative Trait LociAnalgesics, OpioidCasein Kinase 1 epsilonCentral Nervous System Stimulants

Identifiers

PMID22089318
PMCPMC3280656
OpenAlexW1987215054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.